Loading…
Lobbying Spend
—
Filings
26
Firms Hired
1
Active Period
2018–2024
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Chronic Kidney Disease Improvement in Research and Treatment Act of 2023
2024 · first_quarter · Firm: LESTER HEALTH LAW PLLC
Medicare ESRD PPS and reimbursement for innovative products; HR 5027 Restore Protections for Dialysis Patients Act
Client expense: — · Firm income: —
Matched citations: HR 5027
Chronic Kidney Disease Improvement in Research and Treatment Act of 2021
2022 · fourth_quarter · Firm: LESTER HEALTH LAW PLLC
ESRD prospective payment system CY 2022 proposed rule and guidance; Medicare Advantage Program; S. 1971/H.R. 4065 "Chronic Kidney Disease Improvement in Research and Treatment Act of 2021."
Client expense: — · Firm income: —
Matched citations: H.R. 4065
Chronic Kidney Disease Improvement in Research and Treatment Act of 2021
2022 · fourth_quarter · Firm: LESTER HEALTH LAW PLLC
ESRD prospective payment system CY 2022 proposed rule and guidance; Medicare Advantage Program; S. 1971/H.R. 4065 "Chronic Kidney Disease Improvement in Research and Treatment Act of 2021."
Client expense: — · Firm income: —
Matched citations: S. 1971
Chronic Kidney Disease Improvement in Research and Treatment Act of 2021
2022 · third_quarter · Firm: LESTER HEALTH LAW PLLC
ESRD prospective payment system CY 2022 proposed rule and guidance; Medicare Advantage Program; S. 1971/H.R. 4065 "Chronic Kidney Disease Improvement in Research and Treatment Act of 2021."
Client expense: — · Firm income: —
Matched citations: H.R. 4065
Chronic Kidney Disease Improvement in Research and Treatment Act of 2021
2022 · third_quarter · Firm: LESTER HEALTH LAW PLLC
ESRD prospective payment system CY 2022 proposed rule and guidance; Medicare Advantage Program; S. 1971/H.R. 4065 "Chronic Kidney Disease Improvement in Research and Treatment Act of 2021."
Client expense: — · Firm income: —
Matched citations: S. 1971
Chronic Kidney Disease Improvement in Research and Treatment Act of 2021
2022 · second_quarter · Firm: LESTER HEALTH LAW PLLC
ESRD prospective payment system CY 2022 proposed rule and guidance; Medicare Advantage Program; S. 1971/H.R. 4065 "Chronic Kidney Disease Improvement in Research and Treatment Act of 2021."
Client expense: — · Firm income: $12,000
Matched citations: H.R. 4065
Chronic Kidney Disease Improvement in Research and Treatment Act of 2021
2022 · second_quarter · Firm: LESTER HEALTH LAW PLLC
ESRD prospective payment system CY 2022 proposed rule and guidance; Medicare Advantage Program; S. 1971/H.R. 4065 "Chronic Kidney Disease Improvement in Research and Treatment Act of 2021."
Client expense: — · Firm income: $12,000
Matched citations: S. 1971
Chronic Kidney Disease Improvement in Research and Treatment Act of 2021
2022 · first_quarter · Firm: LESTER HEALTH LAW PLLC
ESRD prospective payment system CY 2022 proposed rule and guidance; Medicare Advantage Program; S. 1971/H.R. 4065 "Chronic Kidney Disease Improvement in Research and Treatment Act of 2021."
Client expense: — · Firm income: $15,000
Matched citations: H.R. 4065
Chronic Kidney Disease Improvement in Research and Treatment Act of 2021
2022 · first_quarter · Firm: LESTER HEALTH LAW PLLC
ESRD prospective payment system CY 2022 proposed rule and guidance; Medicare Advantage Program; S. 1971/H.R. 4065 "Chronic Kidney Disease Improvement in Research and Treatment Act of 2021."
Client expense: — · Firm income: $15,000
Matched citations: S. 1971
Source: Senate LDA